What is the recommended protocol for managing cancer pain?

Cancer Pain Management Protocol

Follow the WHO analgesic ladder approach with regular pain assessment using numerical rating scales (0-10), prescribing analgesics around-the-clock with breakthrough doses, and starting with oral morphine as the first-line strong opioid for moderate-to-severe cancer pain. 1

Pain Assessment Framework

Assess pain intensity at every patient contact using validated scales 1, 2:

• Numerical Rating Scale (NRS): 0-10 scale
• Visual Analogue Scale (VAS): Continuous line measurement
• Verbal Rating Scale (VRS): Descriptive terms

Classify pain severity:

• Mild pain: 1-3
• Moderate pain: 4-7
• Severe pain: 8-10 3

Characterize pain type 2:

• Nociceptive: Somatic (bone) or visceral (organ) - described as aching, throbbing, cramping
• Neuropathic: Nerve damage - described as shooting, sharp, stabbing, tingling

Stepwise Pharmacologic Management

Step 1: Mild Pain (NRS 1-3)

Start with non-opioid analgesics 1, 4:

• Acetaminophen/Paracetamol: 500-1000 mg every 4-6 hours (maximum 4000-6000 mg/day)
• NSAIDs (if not contraindicated):
  • Ibuprofen: 400-600 mg every 6-8 hours (maximum 2400 mg/day)
  • Naproxen: 250-500 mg twice daily (maximum 1000 mg/day)
  • Diclofenac: 50 mg 3-4 times daily (maximum 150 mg/day)

Caution: NSAIDs require gastroprotection for prolonged use; monitor for GI and renal toxicity 5

Step 2: Moderate Pain (NRS 4-7)

Add weak opioids OR low-dose strong opioids 1, 6:

Weak opioid options:

• Tramadol: 50-100 mg every 4-6 hours (maximum 400 mg/day)
• Codeine: 30-60 mg every 4 hours (maximum 240 mg/day with acetaminophen)
• Dihydrocodeine: 60-120 mg modified release every 12 hours (maximum 240 mg/day)

Alternative - Low-dose strong opioids (increasingly preferred):

• Morphine: Starting 20-40 mg oral daily in divided doses 4, 5
• Oxycodone: Starting 20 mg oral daily 4

Continue Step 1 non-opioids unless contraindicated 4

Step 3: Severe Pain (NRS 8-10)

Oral morphine is the first-choice strong opioid 1:

Initial dosing for opioid-naïve patients:

• Immediate-release morphine: 5-10 mg every 4 hours, plus rescue doses every 1 hour as needed 1
• Titrate by 50-100% every 24-48 hours based on total rescue dose requirements 7

Conversion to sustained-release:

• Calculate total 24-hour morphine requirement
• Divide into twice-daily sustained-release doses
• Provide immediate-release morphine for breakthrough pain = 10-15% of total daily dose 1

Key conversion ratios 1:

• Oral to IV/SC morphine: 3:1 (oral requires 2-3x higher dose)
• Oral morphine to oral oxycodone: 1.5:1
• Oral morphine to transdermal fentanyl: Use only when stable (≥60 mg oral morphine/day) 5

Alternative strong opioids:

• Oxycodone: Oral potency 2x morphine 4
• Hydromorphone: Higher potency alternative
• Transdermal fentanyl: 25 mcg/hour patch (only for stable requirements ≥60 mg oral morphine/day) 1, 5
• Methadone: Complex dosing, requires experienced prescriber due to variable half-life 5

Renal impairment considerations 1:

• Fentanyl and buprenorphine are safest in chronic kidney disease stages 4-5 (eGFR <30 mL/min)
• Reduce all opioid doses and frequency with renal dysfunction

Mandatory Opioid Side Effect Management

Prophylactic measures required 1:

• Laxatives: Prescribe routinely for all patients on opioids (stimulant + stool softener) 1
• Antiemetics: Metoclopramide or antidopaminergic drugs for nausea/vomiting 1

Monitor and manage sedation, respiratory depression, and cognitive effects

Adjuvant Analgesics for Neuropathic Pain

Add when neuropathic component identified 7, 1:

First-line anticonvulsants:

• Gabapentin:

  • Start 100-300 mg at bedtime
  • Titrate to 900-3600 mg/day in 2-3 divided doses
  • Increase by 50-100% every few days
  • Slower titration for elderly/frail
  • Adjust for renal insufficiency 7

• Pregabalin:

  • Start 50 mg three times daily
  • Increase to 100 mg three times daily
  • Maximum 600 mg/day in divided doses
  • More efficient GI absorption than gabapentin
  • Adjust for renal insufficiency 7

Tricyclic antidepressants: Consider as alternative first-line 1

Topical agents 7:

• Lidocaine 5% patch: Apply daily to painful site (minimal systemic absorption)
• Diclofenac gel: Apply 3 times daily

Breakthrough Pain Management

Immediate-release opioids are mandatory 1:

• Dose = 10-15% of total daily opioid dose
• Available for use up to hourly
• If >4 breakthrough doses needed per 24 hours, increase baseline long-acting opioid 1, 4

Rapid-onset formulations (faster than oral morphine) 1:

• Intravenous opioids
• Buccal/sublingual/intranasal fentanyl

Predictable pain: Give immediate-release morphine 20 minutes before triggers (movement, swallowing) 1

Bone Metastases-Specific Management

Radiotherapy 1:

• Single 8-Gy dose is standard for painful bone metastases
• Higher/protracted fractionation only for selected cases
• 20 Gy in 5 fractions for neuropathic pain from bone metastases 1

Bone-modifying agents 1:

• Bisphosphonates: Consider for all patients with bone metastases (with/without pain)
• Denosumab: Valid alternative to bisphosphonates
• Preventive dental evaluation required before starting either agent

Radioisotopes: Consider for multiple osteoblastic metastases 1

Interventional Procedures

Celiac plexus block 1:

• Indicated for visceral pain from pancreatic cancer or upper abdominal malignancies
• Safe and effective with significant advantage over standard therapy up to 6 months
• Success decreases with disease outside pancreas (celiac/portal adenopathy)

Intraspinal techniques 1:

• Include as part of pain strategy for refractory cases
• Require specialized team monitoring
• Avoid widespread use

Spinal cord compression 1:

• Early diagnosis and prompt therapy are critical outcome predictors
• Majority receive radiotherapy alone
• Hypofractionated regimen is preferred approach
• Dexamethasone at medium dose 1

Scheduling Principles

Critical prescribing rules 1, 4:

• Prescribe analgesics around-the-clock for persistent pain, NOT "as needed"
• Oral route is first choice for administration 1
• Titrate rapidly to effect
• Reassess pain intensity at specified intervals after each intervention

Opioid Rotation Strategy

When to rotate 1:

• Inadequate analgesia despite dose escalation
• Intolerable side effects
• Poor response to current opioid

Calculate equianalgesic dose of new opioid, then reduce by 25-50% to account for incomplete cross-tolerance

Psychosocial Support Requirements

Patient/family education 7:

• Pain relief is medically important; no benefit to suffering
• Pain can usually be well-controlled
• Taking analgesics on schedule improves control
• Many options available if initial treatment fails
• Morphine-like medications rarely cause addiction when treating cancer pain
• Medications work now AND later (tolerance is manageable)
• Proper safeguarding of controlled substances required

Coping skills training 7:

• Acute pain: Breathing exercises, distraction, cognitive coping
• Chronic pain: Add relaxation, guided imagery, graded tasks, hypnosis

Multidisciplinary team may include: oncologist, nurse, pain specialist, palliative care clinician, physiatrist, neurologist, psychologist, social worker, psychiatrist, physical therapist, spiritual counselor 7

Common Pitfalls to Avoid

• Never use "as needed" scheduling alone for persistent cancer pain
• Don't delay strong opioids - low-dose morphine is appropriate for moderate pain
• Don't forget breakthrough medication - always prescribe with long-acting opioids
• Don't ignore constipation prophylaxis - laxatives are mandatory, not optional
• Don't use transdermal fentanyl for unstable or rapidly escalating pain
• Don't underdose rescue medication - 10-15% of total daily dose is required
• Don't overlook neuropathic component - requires adjuvant analgesics, not just opioid escalation